• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Holy Name to Offer Needle-Free Blood Draws for Inpatients, First Hospital in NJ

by Fred Pennic 02/15/2021 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

– Holy Name Medical Center announced that it is the first hospital in New Jersey among a growing number of health systems nationwide to offer needle-free blood draws for inpatients using the PIVO™ device from Velano Vascular.

– As part of this effort, Holy Name is deploying a new telepresence technology, also provided by Velano, to train staff virtually on the PIVO procedure in accordance with COVID-19 safety protocols.

– By adopting this new standard of care known as One-Stick Hospitalization, Holy Name is again leading the charge for better medicine and building on a number of other recent landmark achievements.

– With this procedure, Holy Name staff can extract high quality blood draws easily and humanely from patients’ indwelling IV lines without requiring additional needle sticks, resulting in a safer, better experience.

– To train staff on proper use of Velano’s technology, Holy Name has deployed Velano Vascular’s virtual training platform. The company’s remotely piloted trainers enable Holy Name staff to receive real-time, bedside training from Velano nurse educators while limiting in-person interaction and exposure during the pandemic.

PIVO: Needle-Free Blood Draw Device

PIVO is a needle-free, single-use, sterile device that temporarily attaches to a peripheral IV catheter to collect a fresh venous sample. Using the existing PIV line as a conduit to the vein, a flexible, internal flow tube is advanced through the PIV, beyond the catheter tip, and into the vessel to collect a blood sample. This flow tube is designed to extend beyond the suboptimal draw conditions around the IV to reach vessel locations where blood flow is optimal for aspiration. Once blood collection is complete, the device is retracted, removed from the PIV, and discarded.

PIVO Benefits for Hospitals & Patients

For hospitals that want to reduce painful blood collection ‘sticks’, preserve patient’s veins, and minimize reliance on central lines for blood draws, PIVO is a revolutionary vascular access device that expands the use of peripheral lines for high-quality blood draws.  PIVO provides significant, measurable value in patient experience, organizational risk, operating efficiencies, and overall quality of care.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: blood collection, Health Systems, Patient Experience, risk, Velano Vascular

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Aligning IT & Clinical Teams: How to Reduce Friction and Improve Communication

Most-Read

Oracle Lays Off 539 Kansas City Employees as Focus Shifts to AI Data Centers

Oracle Lays Off 539 Kansas City Employees as Focus Shifts to AI Data Centers

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

HHS Reverses 2024 Tech Reorganization: Why HHS Just Stripped AI and Cyber Operations Out of the ONC

How Small Medical Practices Can Build HIPAA-Aligned DevSecOps Without Enterprise Budgets

How Small Medical Practices Can Build HIPAA-Aligned DevSecOps Without Enterprise Budgets

Insilico Medicine and Eli Lilly Form $2.75B AI Drug Discovery Collaboration

Insilico Medicine and Eli Lilly Form $2.75B AI Drug Discovery Collaboration

Microsoft Copilot Health, Integrates Apple Health, Oura, and 50,000 EHRs in New AI Push

Microsoft Launches Copilot Health, Integrates Apple Health, Oura, and 50,000 EHRs in New AI Push

Health Recovery Solutions (HRS) Acquires Rimidi for Chronic Care Management and RPM Integration

Health Recovery Solutions (HRS) Acquires Rimidi for Chronic Care Management and RPM Integration

RadNet Subsidiary DeepHealth Acquires French Radiology AI Leader Gleamer

RadNet’s $269M AI Play: DeepHealth Acquires French AI Gleamer

Walgreens Launches Virtual Weight Management Platform for Self-Pay GLP-1 Patients

Walgreens Launches Virtual Weight Management Platform for Self-Pay GLP-1 Patients

KLAS Digital Pathology 2026 Report: Top IMS, Scanner, and AI Vendors Evaluated

KLAS Digital Pathology 2026 Report: Top IMS, Scanner, and AI Vendors Evaluated

The "Platform" Squeeze: Epic Releases Native AI Charting, Putting Venture-Backed Scribes on Notice

The “Platform” Squeeze: Epic Releases Native AI Charting, Putting Venture-Backed Scribes on Notice

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |